Cancer Letters
Volume 286, Issue 2 , Pages 232-239 , 28 December 2009

Wortmannin potentiates roscovitine-induced growth inhibition in human solid tumor cells by repressing PI3K/Akt pathway

  • Feng Zhang

      Affiliations

    • Department of Pharmacology, The Fourth Military Medical University, Xi’an 710032, China
    • ,
  • Tao Zhang

      Affiliations

    • Department of Thoracic Surgery, Tangdu Hospital, The Fourth Military Medical University, Xi’an 710038, China
    • Corresponding Author InformationCorresponding author. Tel.: +86 29 8477 7737; fax: +86 29 8477 7436.
    • ,
  • Tao Jiang

      Affiliations

    • Department of Thoracic Surgery, Tangdu Hospital, The Fourth Military Medical University, Xi’an 710038, China
    • ,
  • Rong Zhang

      Affiliations

    • Department of Pharmacology, The Fourth Military Medical University, Xi’an 710032, China
    • ,
  • Zeng-hui Teng

      Affiliations

    • Department of Pharmacology, The Fourth Military Medical University, Xi’an 710032, China
    • ,
  • Chen Li

      Affiliations

    • Department of Pharmacology, The Fourth Military Medical University, Xi’an 710032, China
    • ,
  • Zhong-Ping Gu

      Affiliations

    • Department of Thoracic Surgery, Tangdu Hospital, The Fourth Military Medical University, Xi’an 710038, China
    • ,
  • Qibing Mei

      Affiliations

    • Department of Pharmacology, The Fourth Military Medical University, Xi’an 710032, China

Received 12 October 2008 ,Revised 3 March 2009 ,Accepted 27 May 2009.

References 

  1. Meijer L, Borgne A, Mulner O, et al. Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and cdk5. Eur. J. Biochem. 1997;243:527–536
  2. Tirado OM, Mateo-Lozano S, Notario V. Roscovitine is an effective inducer of apoptosis of Ewing’s sarcoma family tumor cells in vitro and in vivo. Cancer Res. 2005;54:9320–9327
  3. Mohapatra S, Chu B, Zhao XH, et al. Accumulation of p53 and reductions in XIAP abundance promote the apoptosis of prostate cancer cells. Cancer Res. 2005;65:7717–7723
  4. Lacrima K, Valentini A, Lambertini C, et al. In vitro activity of cyclin-dependent kinase inhibitor CYC202 (Seliciclib, R-roscovitine) in mantle cell lymphomas. Ann. Oncol. 2005;16:1169–1176
  5. Mohapatra S, Chu B, Wei S, et al. Roscovitine inhibits STAT5 activity and induces apoptosis in the human leukemia virus type 1-transformed cell line MT-2. Cancer Res. 2003;63:8523–8530
  6. Zhang F, Zhang T, Gu ZP, et al. Enhancement of radiosensitivity by roscovitine pretreatment in human non-small cell lung cancer A549 cells. J. Radiat. Res. 2008;49:541–548
  7. Zhivotovsky B, Orrenius S. Defects in the apoptotic machinery of cancer cells: role in drug resistance. Semin. Cancer Biol. 2003;13:125–134
  8. Itoh N, Semba S, Ito M, et al. Phosphorylation of Akt/PKB is required for suppression of cancer cell apoptosis and tumor progression in human colorectal carcinoma. Cancer. 2002;94:3127–3134
  9. Mungamuri SK, Yang X, Thor AD, et al. Survival signaling by Notch1: mammalian target of rapamycin (mTOR)-dependent inhibition of p53. Cancer Res. 2006;66:4715–4724
  10. Corvera S, Czech MP. Direct targets of phosphoinositide 3-kinase products in membrane traffic and signal transduction. Trends Cell Biol. 1998;8:442–446
  11. Datta SR, Dudek H, Tao X, et al. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell. 1997;91:231–241
  12. Havasi A, Li ZJ, Wang ZY, et al. Hsp27 inhibits Bax activation and apoptosis via a PI3 kinase-dependent mechanism. J. Biol. Chem. 2008;283:12305–12313
  13. Cardone MH, Roy N, Stennicke HR. Et al., Regulation of cell death protease caspase-9 by phosphorylation. Science. 1998;282:1318–1321
  14. Liu Z, Roberts TM. Human tumor mutants in the p110α subunit of PI3K. Cell Cycle. 2006;5:675–677
  15. Huang C, Mandelker D, Gabelli SB, et al. Insights into the oncogenic effects of PIk3CA mutations from the structure of p110α/p85α. Cell Cycle. 2008;7:1151–1156
  16. Kang S, Bader AG, Zhao L, et al. Mutated PI 3-kinases: cancer targets on a silver platter. Cell Cycle. 2005;4:578–581
  17. Samuels Y, Ericson K. Oncogenic PI3K and its role in cancer. Curr. Opin. Oncol. 2006;18:77–82
  18. Ng SSW, Tsao MS, Chow S, et al. Inhibition of phosphatidylinositide 3-kinase enhances gemcitabine-induced apoptosis in human pancreatic cancer cells. Cancer Res. 2000;60:5451–5455
  19. Yu C, Rahmani M, Dai Y, et al. The lethal effects of pharmacological cyclin-dependent kinase inhibitors in human leukemia cells procede through a phosphatidylinositol 3-kinase/Akt-dependent process. Cancer Res. 2003;63:1822–1833
  20. Cory AH, Somerville L, Cory JG. Blockage of cyclin cdk’s, PKC and phosphoinositol 3-kinase pathways leads to augmentation of apoptosis in drug-resistant leukemia cells: evidence for interactive effects of flavopiridol, LY 294002, roscovitine, wortmannin and UCN-01. Anticancer Res. 2005;25:101–106
  21. Powis G, Bonjouklian R, Berggren MM, et al. Wortmannin, a potent and selective inhibitor of phosphatidylinositol-3-kinase. Cancer Res. 1994;54:2419–2423
  22. Okada T, Sakuma L, Fukui Y, et al. Blockage of chemotactic peptide-induced stimulation of neutrophils by wortmannin as a result of selective inhibition of phosphatidylinositol 3-kinase. J. Biol. Chem. 1994;269:3563–3567
  23. Kroemer G. Mitochondrial implication in apoptosis: towards an endosymbiont hypothesis of apoptosis evolution. Cell Death Differ. 1997;4:443–456
  24. Reed JC. Cytochrome c: can’t live with it—can’t live without it. Cell. 1999;91:559–562
  25. Susin SA, Zamzami N, Castedo M, et al. Bcl-2 inhibits the mitochondrial release of an apoptogenic protease. J. Exp. Med. 1996;184:1331–1341
  26. Antignani A, Youle RJ. How do Bax and Bak lead to permeabilization of the outer mitochondrial membrane?. Curr. Opin. Cell Biol. 2006;18:685–689
  27. Engelman JA, Luo J, Cantley LC. The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism. Nat. Rev. Genet. 2006;7:606–619
  28. Okudela K, Hayashi H, Ito T, et al. K-ras gene mutation enhances motility of immortalized airway cells and lung adenocarcinoma cells via Akt activation. Am. J. Pathol. 2004;164:91–100
  29. Wesierska-Gadek J, Gueorguieva M, Horky M. Roscovitine-induced up-regulation of p53AIP1 protein precedes the onset of apoptosis in human MCF-7 breast cancer cells. Mol. Cancer Ther. 2005;4:113–124
  30. Xiao D, Singh SV. Diallyl trisulfide, a constituent of processed garlic, inactivates Akt to trigger mitochondrial translocation of BAD and caspase-mediated apoptosis in human prostate cancer cells. Carcinogenesis. 2006;27:533–540
  31. Gardai SJ, Hildeman DA, Frankel SK, et al. Phosphorylation of Bax Ser184 by Akt regulates its activity and apoptosis in neutrophils. J. Biol. Chem. 2004;279:21085–21095
  32. Kim HJ, Oh JE, Kim SW, et al. Ceramide induces p38 MAPK-dependent apoptosis and Bax translocation via inhibition of Akt in HL-60 cells. Cancer Lett. 2008;206:88–95
  33. Ling YH, Lin R, Perez-Soler R. Erlotinib induces mitochondrial-mediated apoptosis in human H3255 non-small-cell lung cancer cells with epidermal growth factor receptorL858R mutation through mitochondrial oxidative phosphorylation-dependent activation of BAX and BAK. Mol. Pharmacol. 2008;74:793–806
  34. De Giorgi F, Lartigue L, Bauer MK, et al. The permeability transition pore signals apoptosis by directing Bax translocation and multimerization. FASEB J. 2002;16:607–609

PII: S0304-3835(09)00396-6

doi: 10.1016/j.canlet.2009.05.039

Cancer Letters
Volume 286, Issue 2 , Pages 232-239 , 28 December 2009

Article Tools

* Image Usage & Resolution